Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data

JCO Precision Oncology

Volumn 2017, Issue 1, 2017, Pages 1-17

  Middha, Sumit ^a   Zhang, Liying ^a   Nafa, Khedoudja ^a   Jayakumaran, Gowtham ^a   Wong, Donna ^a   Kim, Hyunjae R ^a   Sadowska, Justyna ^a   Berger, Michael F ^a   Delair, Deborah F ^a   Shia, Jinru ^a   Stadler, Zsofia ^a   Klimstra, David S ^a   Ladanyi, Marc ^a   Zehir, Ahmet ^a   Hechtman, Jaclyn F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EXON; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NEXT GENERATION SEQUENCING; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SOLID MALIGNANT NEOPLASM; VALIDATION STUDY;

EID: 85041706640     PISSN: None     EISSN: 24734284     Source Type: Journal    
DOI: 10.1200/PO.17.00084     Document Type: Article

References (18)

1. Benson AB III, Venook AP, Cederquist L, et al: Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 15:370-398, 2017
2. Hechtman JF, Middha S, Stadler ZK, et al: Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerations. Fam Cancer 10.1007/s10689-017-9993-x [epub ahead of print on April 12, 2017]
3. Ribic CM, Sargent DJ, Moore MJ, et al: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. New Engl J Med 349:247-257, 2003
4. Le DT, Uram JN, Wang H, et al: PD-1 blockade in tumors with mismatch-repair deficiency.NEngl J Med 372:2509-2520, 2015
5. Le DT, Durham JN, Smith KN, et al: Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357:409-413, 2017
6. Hause RJ, Pritchard CC, Shendure J, et al: Classification and characterization of microsatellite instability across 18 cancer types. Nat Med 22:1342-1350, 2016
7. Cheng DT, Mitchell TN, Zehir A, et al: Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 17:251-264, 2015
8. Zehir A, Benayed R, Shah RH, et al: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10, 000 patients. Nat Med 23:703-713, 2017
9. Niu B, Ye K, Zhang QY, et al: MSIsensor: Microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics 30:1015-1016, 2014
10. GitHub: MSKCC/mutational signatures. https://github.com/mskcc/mutation-signatures
11. Stadler ZK, Battaglin F, Middha S, et al: Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels. J Clin Oncol 34:2141-2147, 2016
12. Henninger EE, Pursell ZF: DNA polymerase e and its roles in genome stability. IUBMB Life 66:339-351, 2014
13. Salipante SJ, Scroggins SM, Hampel HL, et al: Microsatellite instability detection by next generation sequencing. Clin Chem 60:1192-1199, 2014
14. Hempelmann JA, Scroggins SM, Pritchard CC, et al: MSIplus for integrated colorectal cancer molecular testing by next-generation sequencing. J Mol Diagn 17:705-714, 2015
15. Nowak JA, Yurgelun MB, Bruce JL, et al: Detection of mismatch repair deficiency and microsatellite instability in colorectal adenocarcinoma by targeted next-generation sequencing. J Mol Diagn 19:84-91, 2017
16. Huang MN, McPherson JR, Cutcutache I, et al: MSIseq: Software for assessing microsatellite instability from catalogs of somatic mutations. Sci Rep 5:13321, 2015
17. Kautto EA, Bonneville R, Miya J, et al: Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. Oncotarget 8:7452-7463, 2017
18. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn 10: 293-300, 2008